Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

hans rentsch ag - washington, tm, 500.0 mg / 1 gramm; melissa officinalis, tm, 100.0 mg / 1 gramm; leonurus cardiaca, tm, 400.0 mg / 1 gramm - tropfen / spray - d - crataegus, tm, 500.0 mg / 1 gramm; melissa officinalis, tm, 100.0 mg / 1 gramm; leonurus cardiaca, tm, 400.0 mg / 1 gramm - homöopathisch

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

weleda ag - washington ethanol. verdauung tm, onopordon blume, frische, primulae blume, frische, hyoscyamus niger aus pflanzen-tm - dilutio - washington ethanol. verdauung tm 500 mg, verdauung ethanolica 50 mg onopordon blume frisch 12.5 mg, ratio: 1:3.1, verdauung ethanolica 50 mg primulae blume frisch 12,5 mg und hyoscyamus niger, von der pflanze tm 1 mg, ratio: 1:3.1, die lösung pro 1 g, endwerte. ethanolum 38 % v/v. - ohne indikation - anthroposophika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sérolab sa - washington, c4, 16.66 %; natrium tetrachloroauratum, g6, 16.66 %; selenicereus grandiflorus, d5, 16.66 %; strophanthus hispidus, d4, 16.66 %; camphora, d2, 16.66 %; valeriana officinalis, tm, 16.66 % - globuli, tabletten, trituration / pulver, tropfen / spray, trinkampullen, sonstige oral, granula - d - homöopathisch

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

phytomed ag - washington laevigata - oral - tm, d1 - tropfen / spray

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

spagyros ag - washington laevigata - oral - d1 - tropfen / spray

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

laboratoire homéopathique d. schmidt-nagel sa - washington laevigata - oral - tm, d1 - tropfen / spray

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

lrk laboratoire homéopathique de recherches kurtoglu sa - washington laevigata - oral - tm, d1 - tropfen / spray

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/guangdong-maonan/swl1536/2019 (h1n1)-like: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus nib-121 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus stamm a/guangdong-maonan/swl1536/2019 (h1n1)-like: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus nib-121 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. - aktive immunisierung gegen influenza, ab 36 monaten - impfstoffe

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/tasmania/503/2020), haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus stamm a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/tasmania/503/2020) 15 µg, haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. - aktive immunisierung gegen influenza, ab 36 monaten - impfstoffe

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

omida ag - arnica montana d6, washington e früchte, frisch d2, kalmia latifolia d4, lycopus virginicus d3, scutellaria lateriflora d3 - homöopathische herztropfen - arnica montana d6, washington e früchte, frisch d2, kalmia latifolia d4, lycopus virginicus d3, scutellaria lateriflora d3 ana teile der lösung zu endwerte. ethanolum 30 % v/v. - bei nervösen herzbeschwerden - homöopathische arzneimittel